News
In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock ...
It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...
MarketBeat on MSN
Eli Lilly's Oral GLP-1 Breakthrough Could Change Everything
Eli Lilly and Company (NYSE: LLY) has been one of the best-performing stocks outside of the AI-enhanced Magnificent 7 stocks ...
Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...
In 2015, Julianne Moore won the Academy Award for Best Actress for her starring role in Still Alice, portraying a middle-aged woman diagnosed with early onset Alzheimer’s disease. A decade later, ...
Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...
The Virtus Silvant Focused Growth Fund returned +20.87% (Class INST) for the quarter, compared with the Russell 1000 Growth ...
Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...
Shares of D-Wave Quantum are higher by 35% over the past week. The recent rally is fueled by favorable macroeconomic ...
Novo Nordisk is “no longer the elephant in the room,” Berenberg analysts say. Eli Lilly may have to fight hard to keep its ...
TipRanks on MSN
Eli Lilly’s Orforglipron Study: A Potential Game-Changer in Obesity and Diabetes Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company recently completed a ...
Nvov Nordisk stock rose after a study showed Ozempic reduced the risk of heart attack, stroke and death by 23% compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results